Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000897712 | SCV001041872 | likely benign | EGFR-related lung cancer | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003476915 | SCV004221879 | benign | not provided | 2022-11-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004948144 | SCV005579607 | likely benign | Hereditary cancer-predisposing syndrome | 2024-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV005246602 | SCV005896742 | benign | Lung cancer | 2024-10-16 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Laboratory for Molecular Medicine, |
RCV000038382 | SCV000062054 | likely benign | not specified | 2009-03-18 | no assertion criteria provided | clinical testing |